|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent ARQL insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why ARQL insider buys are important for investors to follow.
Date | Insider | Price | Amount |
6-27-2019 Insider Buy |
Ran Nussbaum Director |
$9.75
CAGR »
|
$2,999,997.00 307,692 shares |
7-13-2018 Insider Buy |
Ran Nussbaum Director |
$5.50
CAGR »
|
$999,999.00 181,818 shares |
5-18-2018 Insider Buy |
Ran Nussbaum Director |
$3.29
CAGR »
|
$28,330.19 8,611 shares |
5-18-2018 Insider Buy |
Paolo Pucci Chief Executive Officer |
$3.39
CAGR »
|
$50,848.50 15,000 shares |
5-11-2018 Insider Buy |
Ronald M. Lindsay Director |
$2.69
CAGR »
|
$18,588.60 6,900 shares |
5-14-2018 Insider Buy |
Patrick J. Zenner Director |
$2.96
CAGR »
|
$24,986.65 8,446 shares |
5-10-2018 Insider Buy |
Ronald M. Lindsay Director |
$2.67
CAGR »
|
$63,836.90 23,900 shares |
5-10-2018 Insider Buy |
Paolo Pucci Chief Executive Officer |
$2.64
CAGR »
|
$3,427.06 1,300 shares |
9-7-2017 Insider Buy |
Paolo Pucci Chief Executive Officer |
$1.15
CAGR »
|
$1,261.09 1,101 shares |
9-6-2017 Insider Buy |
Paolo Pucci Chief Executive Officer |
$1.15
CAGR »
|
$18,840.15 16,397 shares |
9-5-2017 Insider Buy |
Paolo Pucci Chief Executive Officer |
$1.14
CAGR »
|
$21,843.59 19,156 shares |
8-29-2017 Insider Buy |
Paolo Pucci Chief Executive Officer |
$1.05
CAGR »
|
$315.00 300 shares |
8-28-2017 Insider Buy |
Paolo Pucci Chief Executive Officer |
$1.05
CAGR »
|
$3,115.23 2,970 shares |
8-25-2017 Insider Buy |
Paolo Pucci
|
$1.05
CAGR »
|
$9,947.86 9,492 shares |
12-17-2015 Insider Buy |
Michael D. Loberg Director |
$2.16
CAGR »
|
$8,030.44 3,719 shares |
12-16-2015 Insider Buy |
Michael D. Loberg Director |
$2.14
CAGR »
|
$2,633.23 1,231 shares |
12-15-2015 Insider Buy |
Paolo Pucci Chief Executive Officer |
$2.16
CAGR »
|
$2,771.28 1,283 shares |
12-11-2015 Insider Buy |
Patrick J. Zenner Director |
$2.15
CAGR »
|
$4,947.07 2,300 shares |
12-11-2015 Insider Buy |
Paolo Pucci Chief Executive Officer |
$2.10
CAGR »
|
$2,323.81 1,108 shares |
12-10-2015 Insider Buy |
Paolo Pucci Chief Executive Officer |
$2.10
CAGR »
|
$15,963.06 7,609 shares |
3-11-2015 Insider Buy |
Patrick J. Zenner Director |
$2.32
CAGR »
|
$24,646.81 10,625 shares |
11-20-2014 Insider Buy |
Paolo Pucci Chief Executive Officer |
$1.26
CAGR »
|
$6,298.00 5,000 shares |
11-14-2014 Insider Buy |
William G. Messenger Director |
$1.21
CAGR »
|
$10,284.15 8,500 shares |
11-14-2014 Insider Buy |
Patrick J. Zenner Director |
$1.20
CAGR »
|
$24,952.26 20,830 shares |
11-13-2014 Insider Buy |
Susan L. Kelley Director |
$1.20
CAGR »
|
$60,160.00 50,000 shares |
9-4-2014 Insider Buy |
Paolo Pucci Chief Executive Officer |
$1.30
CAGR »
|
$6,525.00 5,000 shares |
5-23-2014 Insider Buy |
Paolo Pucci Chief Executive Officer |
$1.40
CAGR »
|
$7,010.50 5,000 shares |
5-20-2014 Insider Buy |
Paolo Pucci Chief Executive Officer |
$1.42
CAGR »
|
$7,123.50 5,000 shares |
3-17-2014 Insider Buy |
Patrick J. Zenner Director |
$2.12
CAGR »
|
$10,008.53 4,715 shares |
3-13-2014 Insider Buy |
Paolo Pucci Chief Executive Officer |
$2.10
CAGR »
|
$20,990.00 10,000 shares |
6-12-2012 Insider Buy |
Patrick J. Zenner Director |
$6.47
CAGR »
|
$25,871.20 4,000 shares |
6-6-2012 Insider Buy |
Paolo Pucci Chief Executive Officer |
$6.24
CAGR »
|
$29,684.45 4,754 shares |
6-6-2012 Insider Buy |
Brian Schwartz Chief Medical Officer |
$6.26
CAGR »
|
$29,411.66 4,700 shares |
6-6-2012 Insider Buy |
Peter S. Lawrence President & COO |
$6.25
CAGR »
|
$6,254.00 1,000 shares |
12-2-2011 Insider Buy |
Patrick J. Zenner Director |
$5.53
CAGR »
|
$24,320.56 4,400 shares |
Also See: Institutional Holders of ARQL
Also See: SEC filings
Below we present the annualized performance delivered by ARQL stock since 6-27-2019 (the date of the most recent
insider purchase). The performance of the investment from the time ARQL insider buying occurred is the ultimate
test of whether insiders were right about ARQL being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/28/2019 |
|
End date: |
01/16/2020 |
|
Start price/share: |
$11.01 |
|
End price/share: |
$20.00 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
81.65% |
|
Annualized Gain: |
147.54% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$18,165.00 |
|
Years: |
0.55 |
|
ARQL Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent ARQL insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ARQL
|
|